معرفی
James P. Thomas, MD, PhD, serves as Professor in the Department of Medicine (Hematology/Oncology) at the Medical College of Wisconsin with secondary faculty appointment in Biochemistry, joining the institution in September 2010 after prior leadership roles at the University of Wisconsin and Ohio State Comprehensive Cancer Center.
His educational foundation includes:
- PhD in Biochemistry from the Medical College of Wisconsin (1989)
- MD from the Medical College of Wisconsin (1991)
Dr. Thomas maintains a dual clinical-translational focus on gastrointestinal cancer therapeutics and oncology drug development, with sustained investigation into reactive oxygen species mechanisms in carcinogenesis and treatment resistance. His work bridges molecular pathway analysis (particularly p38γ MAPK signaling) with clinical application in pancreatic, colorectal, and gastric malignancies.
Analysis of his 12 most recent publications (2014-2020) reveals concentrated expertise in gastrointestinal oncology, featuring molecular tumor profiling, targeted therapy development (including glutathione pro-drug systems and FOLFIRINOX optimization), and clinical trial methodology. Key themes include pancreatic cancer metabolism, metastatic disease management, and biomarker-driven treatment personalization.
His leadership extends to chairing the American Association of Cancer Institutes Clinical Research Group and prior service on the NCCN Panel for Colorectal Cancers, reflecting significant contributions to national oncology guidelines and clinical trial infrastructure.
